m+Medelevator.RU
← Поиск публикаций
Nippon Ganka Gakkai zasshi · 2004

[Retinopathy of prematurity in extremely low birth weight infants: a Tokyo multicenter study].

Аннотация на английскомСтатьяМногоцентровое исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Hiraoka Miina, Watanabe Toyoko, Kawakami Tadashi, Ito Rei, Takigawa Itsuro, Suzumura Hirotaka, Tada Hiroshi, Kubota Yoshimi, Hayashi Yoshihiro, Yoshida Masaki, Kabe Kazuhiko, Nishida Akira, Kondo Masatoshi, Takeuchi Toshio, Ueda Toshihiko, Miyajima Tasuku, Muramatsu Daisuke, Sakuma Izumi, Toyoguchi Mitsuko, Shima Yoshio, Takada Masaaki, Nakayama Reifui, Hosaka Atsuto, Yokoyama Toshiyuki, Hasegawa Ren, Hoshi Jun, Soeda Atsuhiro, Toyoda Mihoko, Saito Tomohiro

Аннотация

OBJECTIVE: To investigate how the increase in survival rate in extremely low birth weight (a birth weight of 1,000 g or less) infants had affected the incidence of retinopathy of prematurity (ROP) and the frequency of laser treatment.

METHODS: We retrospectively reviewed the medical records of 122 surviving premature infants with birthweights less than 1,000 g to determine the severity of ROP observed at 16 neonatal intensive care units in Tokyo between April and October 2002.

RESULTS: The survival rate was 85.6%. The mean gestational age was 26.74 weeks and the mean birth weight was 782.25 g. One-hundred-and-five infants (86.1%) developed ROP, fifty (41.0%) received laser treatment, and six (4.9%) had retinal detachment. The median postmenstrual age (gestational age at birth plus chronological age in weeks, PMA) at the onset of ROP was 32.5 weeks, and the first laser treatment was performed at the median PMA of 35.7 weeks.

CONCLUSIONS: In these extremely low birth weight infants, there was an increase in the survival rate and in the incidence of severe ROP that progressed to the stage that required treatment.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты